Practical modifications of the continual reassessment method for phase i cancer clinical trials
Author:
Affiliation:
1. a Eli Lilly & Company , Lilly Corporate Center , Indianapolis, Indiana, 46285
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,Statistics and Probability
Link
https://www.tandfonline.com/doi/pdf/10.1080/10543409408835079
Reference12 articles.
1. Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
2. Methods for dose finding studies in cancer clinical trials: A review and results of a monte carlo study
3. Design and Analysis of Phase I Clinical Trials
Cited by 194 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adaptive continual reassessment method: A maximum tolerated dose estimation method in phase I clinical trial;Korean Journal of Applied Statistics;2024-08-31
2. Recombinant fragment of human surfactant protein D to prevent neonatal chronic lung disease (RESPONSE): a protocol for a phase I safety trial in a tertiary neonatal unit;BMJ Open;2024-08
3. A novel model of the continual reassessment method in Phase I trial;Scientific Reports;2023-03-28
4. Comparison of design methods for a safety run-in phase of a phase II clinical trial;Clinical Trials;2023-01-11
5. Deep Reinforcement Learning for Bandit Arm Localization;2022 IEEE International Conference on Big Data (Big Data);2022-12-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3